- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
11
11 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.46
7D
-1.9%
1Y
-1.9%
Tong Ren Tang Technologies
Market Cap: HK$5.4b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.14
7D
-1.9%
1Y
-19.8%
Consun Pharmaceutical Group
Market Cap: HK$14.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.38
7D
-4.5%
1Y
82.2%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.1b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.86
7D
1.5%
1Y
17.1%
Essex Bio-Technology
Market Cap: HK$2.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.70
7D
-6.6%
1Y
28.0%
CSPC Pharmaceutical Group
Market Cap: HK$105.1b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.02
7D
4.3%
1Y
74.1%
China Shineway Pharmaceutical Group
Market Cap: HK$6.9b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.05
7D
-2.8%
1Y
0.6%
Shanghai Haohai Biological Technology
Market Cap: HK$10.0b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$23.62
7D
-2.9%
1Y
-15.8%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.24
7D
-0.8%
1Y
6.9%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.15
7D
0%
1Y
-4.2%
Pak Fah Yeow International
Market Cap: HK$744.8m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.39
7D
3.0%
1Y
10.6%